BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 14749474)

  • 1. Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid.
    Ikeda T; Nakata Y; Kimura F; Sato K; Anderson K; Motoyoshi K; Sporn M; Kufe D
    Mol Cancer Ther; 2004 Jan; 3(1):39-45. PubMed ID: 14749474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel triterpenoid CDDO and its derivatives induce apoptosis by disruption of intracellular redox balance.
    Ikeda T; Sporn M; Honda T; Gribble GW; Kufe D
    Cancer Res; 2003 Sep; 63(17):5551-8. PubMed ID: 14500394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer.
    Samudio I; Konopleva M; Hail N; Shi YX; McQueen T; Hsu T; Evans R; Honda T; Gribble GW; Sporn M; Gilbert HF; Safe S; Andreeff M
    J Biol Chem; 2005 Oct; 280(43):36273-82. PubMed ID: 16118208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance.
    Chauhan D; Li G; Podar K; Hideshima T; Shringarpure R; Catley L; Mitsiades C; Munshi N; Tai YT; Suh N; Gribble GW; Honda T; Schlossman R; Richardson P; Sporn MB; Anderson KC
    Blood; 2004 Apr; 103(8):3158-66. PubMed ID: 15070698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition and apoptosis of human multiple myeloma cells induced by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid derivatives.
    Rogers LJ; John T; Park J; Tucker M; Ma H; Wu Y; Rayalam S; Wang X
    Anticancer Drugs; 2020 Sep; 31(8):806-818. PubMed ID: 32304407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.
    Hyer ML; Shi R; Krajewska M; Meyer C; Lebedeva IV; Fisher PB; Reed JC
    Cancer Res; 2008 Apr; 68(8):2927-33. PubMed ID: 18413762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism.
    Ito Y; Pandey P; Place A; Sporn MB; Gribble GW; Honda T; Kharbanda S; Kufe D
    Cell Growth Differ; 2000 May; 11(5):261-7. PubMed ID: 10845427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDDO-imidazolide mediated inhibition of malignant cell growth in Waldenström macroglobulinemia.
    Elsawa SF; Novak AJ; Grote D; Konopleva M; Andreeff M; Witzig TE; Ansell SM
    Leuk Res; 2008 Dec; 32(12):1895-902. PubMed ID: 18468679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of intracellular glutathione contributes to JNK-mediated death receptor 5 upregulation and apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me).
    Yue P; Zhou Z; Khuri FR; Sun SY
    Cancer Biol Ther; 2006 May; 5(5):492-7. PubMed ID: 16582599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells.
    Stadheim TA; Suh N; Ganju N; Sporn MB; Eastman A
    J Biol Chem; 2002 May; 277(19):16448-55. PubMed ID: 11880365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia.
    Konopleva M; Tsao T; Estrov Z; Lee RM; Wang RY; Jackson CE; McQueen T; Monaco G; Munsell M; Belmont J; Kantarjian H; Sporn MB; Andreeff M
    Cancer Res; 2004 Nov; 64(21):7927-35. PubMed ID: 15520199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels.
    Riccioni R; Senese M; Diverio D; Riti V; Mariani G; Boe A; LoCoco F; Foà R; Peschle C; Sporn M; Testa U
    Leuk Res; 2008 Aug; 32(8):1244-58. PubMed ID: 18304628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism.
    Ito Y; Pandey P; Sporn MB; Datta R; Kharbanda S; Kufe D
    Mol Pharmacol; 2001 May; 59(5):1094-9. PubMed ID: 11306692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triterpenoid CDDO-Im downregulates PML/RARalpha expression in acute promyelocytic leukemia cells.
    Ikeda T; Kimura F; Nakata Y; Sato K; Ogura K; Motoyoshi K; Sporn M; Kufe D
    Cell Death Differ; 2005 May; 12(5):523-31. PubMed ID: 15746941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL.
    Suh WS; Kim YS; Schimmer AD; Kitada S; Minden M; Andreeff M; Suh N; Sporn M; Reed JC
    Leukemia; 2003 Nov; 17(11):2122-9. PubMed ID: 12931220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDDO-imidazolide induces DNA damage, G2/M arrest and apoptosis in BRCA1-mutated breast cancer cells.
    Kim EH; Deng CX; Sporn MB; Liby KT
    Cancer Prev Res (Phila); 2011 Mar; 4(3):425-34. PubMed ID: 21372041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The triterpenoid CDDO induces apoptosis in refractory CLL B cells.
    Pedersen IM; Kitada S; Schimmer A; Kim Y; Zapata JM; Charboneau L; Rassenti L; Andreeff M; Bennett F; Sporn MB; Liotta LD; Kipps TJ; Reed JC
    Blood; 2002 Oct; 100(8):2965-72. PubMed ID: 12351409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide.
    Petronelli A; Saulle E; Pasquini L; Petrucci E; Mariani G; Biffoni M; Ferretti G; Scambia G; Benedetti-Panici P; Greggi S; Cognetti F; Russo MA; Sporn M; Testa U
    Cancer Lett; 2009 Sep; 282(2):214-28. PubMed ID: 19364626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
    Ji Y; Lee HJ; Goodman C; Uskokovic M; Liby K; Sporn M; Suh N
    Mol Cancer Ther; 2006 Jun; 5(6):1452-8. PubMed ID: 16818503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells.
    Zhang C; Ni X; Konopleva M; Andreeff M; Duvic M
    J Invest Dermatol; 2004 Aug; 123(2):380-7. PubMed ID: 15245439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.